Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Narcolepsy 1”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Not applicableStudy completedNCT07609537
What this trial is testing

Imagery Control Therapy and Lucid Dreaming for REM-Related Symptoms in Narcolepsy

Who this might be right for
Narcolepsy Type 1Hypnagogic HallucinationsSleep Paralysis+2 more
Institute of Behavioral Sleep Medicine, Colombia 98
Large-scale testing (Phase 3)Study completedNCT06470828
What this trial is testing

TAK-861 for the Treatment of Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1
Takeda 168
Not applicableStudy completedNCT06251063
What this trial is testing

Improving Social Relationships for Adolescents With Central Disorders of Hypersomnolence

Who this might be right for
Narcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia
Boston Children's Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT06809803
What this trial is testing

Extended-release Sodium Oxybate in Children

Who this might be right for
Narcolepsy Type 1 (NT 1)
Stanford University 36
Not applicableStudy completedNCT06531876
What this trial is testing

Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy

Who this might be right for
Narcolepsy Type 1HypersomniaSleep Disorder
Beacon Biosignals 78
Early research (Phase 1)Study completedNCT06462404
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1 (NT1)
Eisai Inc. 22
Early research (Phase 1)Looking for participantsNCT07584434
What this trial is testing

A Phase 1, First-in-human Study of VX-433

Who this might be right for
Narcolepsy Type 1 (NT1)
Vertex Pharmaceuticals Incorporated 118
Large-scale testing (Phase 3)UnknownNCT05914194
What this trial is testing

A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1Narcolepsy With Cataplexy
NLS Pharmaceutics 48
Not applicableLooking for participantsNCT05773872
What this trial is testing

Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia

Who this might be right for
NarcolepsySocial Cognition
Centre Hospitalier Universitaire, Amiens 75
Large-scale testing (Phase 3)Looking for participantsNCT07598708
What this trial is testing

Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

Who this might be right for
Narcolepsy Type 1Narcolepsy Type 2
Centessa Pharmaceuticals (UK) Limited 222
Not applicableStudy completedNCT06241911
What this trial is testing

Transcutaneous Auricular Vagus Nerve Stimulation in Patients With Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1Fmri
Liu Yonghong 60
Not applicableLooking for participantsNCT06457945
What this trial is testing

Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions

Who this might be right for
Narcolepsy Type 1HypersomnolenceIdiopathic Hypersomnia
Hospices Civils de Lyon 180
Testing effectiveness (Phase 2)Study completedNCT06358950
What this trial is testing

Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)

Who this might be right for
Narcolepsy Type 1
Alkermes, Inc. 92
Large-scale testing (Phase 3)Active Not RecruitingNCT07363720
What this trial is testing

A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy

Who this might be right for
Narcolepsy Type 1 (NT1)Narcolepsy With Cataplexy
Takeda 98
Large-scale testing (Phase 3)Looking for participantsNCT07625280
What this trial is testing

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

Who this might be right for
NarcolepsyIdiopathic Hypersomnia
Jazz Pharmaceuticals 120
Testing effectiveness (Phase 2)Ended earlyNCT04820842
What this trial is testing

TAK-994 in Adults With Narcolepsy

Who this might be right for
Narcolepsy Type 1 (NT 1)
Takeda 26
Testing effectiveness (Phase 2)Study completedNCT04072380
What this trial is testing

Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy

Who this might be right for
Narcolepsy
Suven Life Sciences Limited 190
Not applicableUnknownNCT05967832
What this trial is testing

Contribution of 7 Tesla MRI of the Hypothalamus in the Diagnosis of Type 1 Narcolepsy

Who this might be right for
Narcolepsy Type 1
Assistance Publique Hopitaux De Marseille 30
Early research (Phase 1)Ended earlyNCT06179407
What this trial is testing

Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)

Who this might be right for
Narcolepsy
Merck Sharp & Dohme LLC 9
Not applicableNot Yet RecruitingNCT06786377
What this trial is testing

Genetic and Clinical Characterization of Type 1 and 2 Narcolepsy in Adult and Pediatric Black and North African Populations

Who this might be right for
Narcolepsy
Assistance Publique - Hôpitaux de Paris 200
Next Page